MN-166
Showing 1 - 25 of 404
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)
Active, not recruiting
- Glioblastoma
- +3 more
- MN-166
- Temozolomide
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 16, 2022
Amyotrophic Lateral Sclerosis Trial in Charlotte (Placebo (for MN-166), MN-166, riluzole)
Completed
- Amyotrophic Lateral Sclerosis
- Placebo (for MN-166)
- +2 more
-
Charlotte, North CarolinaCarolinas Healthcare System, Dept. of Neurology
Oct 7, 2021
Amyotrophic Lateral Sclerosis Trial in Canada, United States (MN-166, )
Recruiting
- Amyotrophic Lateral Sclerosis
- MN-166
- placebo
-
Orange, California
- +23 more
Jan 24, 2023
Alcohol Use Disorder (AUD), Alcoholism Trial in Philadelphia (Ibudilast, Medical management, Placebo)
Recruiting
- Alcohol Use Disorder (AUD)
- Alcoholism
- Ibudilast
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Center for Studies of Addiction
Jan 17, 2023
Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19 Trial in Toronto (drug, dietary supplement, other)
Not yet recruiting
- Long COVID, Post COVID Condition, Post Acute Sequelae of COVID-19
- Ibudilast
- +3 more
-
Toronto, Ontario, CanadaUniversity Health Network, Osteoporosis Department
Aug 22, 2022
Healthy Volunteers Trial in Garden Grove (MN-166)
Completed
- Healthy Volunteers
- MN-166
-
Garden Grove, CaliforniaCollaborative Neuroscience Network
Jul 13, 2020
Alcohol Use Disorder Trial in Los Angeles (Ibudilast, Placebo oral capsule)
Recruiting
- Alcohol Use Disorder
- Ibudilast
- Placebo oral capsule
-
Los Angeles, CaliforniaUCLA Addictions Laboratory
May 20, 2021
Healthy Volunteers Trial in Cypress (MN-166)
Completed
- Healthy Volunteers
- MN-166
-
Cypress, CaliforniaWCCT Global, Inc.
May 29, 2019
Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in United States (ibudilast, Placebo
Completed
- Multiple Sclerosis, Primary Progressive
- Multiple Sclerosis, Secondary Progressive
- ibudilast
- Placebo oral capsule
-
Birmingham, Alabama
- +27 more
Jul 13, 2020
Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)
Recruiting
- Liver Metastases
- Breast Cancer
- Quiremspheres™
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Nov 16, 2023
Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)
Not yet recruiting
- Membranous Nephropathy
- Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
-
Nice, FranceCHU de NICE
Jul 4, 2023
Holmium-166 Retrospective Collection of Real-World Data
Completed
- Hepatocellular Carcinoma
- Metastatic Cancer
- Selective Internal Radiation Therapy with QuiremSpheresTM Holmium-166 Microspheres
-
Aalst, Belgium
- +11 more
Aug 29, 2022
Pancreas Cancer Trial in Nijmegen (Intratumoral)
Recruiting
- Pancreas Cancer
- Intratumoral
-
Nijmegen, Gelderland, NetherlandsRadboud University Medical Centre
May 19, 2023
Memory Loss, Alzheimer, Dementia Trial in Minneapolis (PorchLight)
Active, not recruiting
- Memory Loss
- +2 more
- PorchLight
-
Minneapolis, MinnesotaUniversity of Minnesota (with Lutheran Social Service of Minneso
Dec 15, 2022
Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)
Not yet recruiting
- Primary Liver Cancer
- Non-Resectable Hepatocellular Carcinoma
- MRI-guided radioembolization
- (no location specified)
Nov 1, 2022
Thin-gingiva Trial in Rohtak (microneedling and hyaluronic acid for increasing gingival thickness in thin gingival phenotype,
Not yet recruiting
- Thin-gingiva
- microneedling and hyaluronic acid for increasing gingival thickness in thin gingival phenotype
- microneedling for increasing gingival thickness in thin gingival phenotype
-
Rohtak, Haryana, IndiaPost Graduate Institute of Dental Sciences
May 11, 2023
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
One-Minute Sit-to-Stand Test in Obese and Overweight Children
Recruiting
- Obese
- +3 more
- assessment study
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Jul 7, 2022
Membranous Nephropathy, Nephrotic Syndrome Trial in Canada, United States (Belimumab, Placebo for Belimumab, Rituximab)
Recruiting
- Membranous Nephropathy
- Nephrotic Syndrome
- Belimumab
- +2 more
-
Birmingham, Alabama
- +16 more
Sep 22, 2022
Injuries Related Work, Illness Related Work, Disability Trial in Rochester (RETAIN Program)
Recruiting
- Injuries Related Work
- +2 more
- RETAIN Program
-
Rochester, MinnesotaMayo Clinic Rochester
Apr 4, 2022
Glaucoma, Cataract Trial in Kuala Lumpur (Lignocaine-loaded maltose microneedle array patch, EMLA 5% patch)
Not yet recruiting
- Glaucoma
- Cataract
- Lignocaine-loaded maltose microneedle array patch
- EMLA 5% patch
-
Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, MalaysiaHospital Canselor Tuanku Muhriz, Universiti Kebangsaan Malaysia
Jan 19, 2023
Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)
Not yet recruiting
- Vaccination; Infection
- Vaccine Adverse Reaction
- Recombinant zoster vaccination
- (no location specified)
Jun 9, 2023
Autoreactive B Cells in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- In vitro assays.
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele D
Nov 2, 2022